VirTra Reports Third Quarter and Nine Months 2025 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 10 2025
0mins
Get Free Real-Time Notifications for Any Stock
Monitor tickers like VTSI with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on VTSI
Wall Street analysts forecast VTSI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VTSI is 8.25 USD with a low forecast of 7.00 USD and a high forecast of 9.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 4.780
Low
7.00
Averages
8.25
High
9.50
Current: 4.780
Low
7.00
Averages
8.25
High
9.50
About VTSI
VirTra, Inc. is a provider of judgmental use of force training simulators and firearms training simulators for the law enforcement, military, and commercial markets. Its patented technologies, software, and scenarios provide intense training for de-escalation, judgmental use-of-force, marksmanship, and related training that mimics real-world situations. Its segments include Simulators and Accessories, Extended Service-type warranties, Customized software and content, Installation and training, Design and Prototyping, and Subscription Training Equipment Partnership (STEP). Installation and training segment include installation of its simulators at specific sites as well as extra training classes preformed onsite, virtually or at the training center. Simulators and Accessories segment includes all variations of the its simulator, simulated recoil kits, Taser, OC Spray, low light devices and refill options. Design and Prototyping segment includes contracts related to hardware development.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
VirTra (VTSI) to Showcase Advanced Simulators at 2026 SHOT Show
- Event Participation: VirTra will showcase its V-300®, V-One™, and V-XR® simulators at the 2026 SHOT Show from January 20-23 in Las Vegas, expected to attract numerous industry professionals.
- Technology Demonstration: During the event, VirTra will conduct live demonstrations highlighting the realism and adaptability of its simulation technologies, aiding law enforcement and military personnel in decision-making training under high-pressure scenarios.
- Market Positioning: The SHOT Show is the world's largest trade event for shooting sports and law enforcement, and VirTra's participation will enhance its influence in the industry while showcasing its leadership in training solutions.
- Customer Engagement: VirTra CEO John Givens emphasized that the SHOT Show provides a valuable opportunity for the company to engage with global customers and industry leaders, demonstrating the realistic scenarios and decision-making capabilities of its comprehensive training platforms.
Continue Reading
VirTra Faces Securities Fraud Investigation After Q3 Earnings Miss
- Performance Decline: VirTra reported a GAAP earnings per share of -$0.03 for Q3 2025, missing the consensus estimate by $0.07, indicating significant financial pressure amid a slower federal funding cycle.
- Revenue Gap: The company's revenue of $5.3 million fell short of consensus by $1.69 million, reflecting the impact of customer acceptances and timing of federal awards on near-term revenue recognition, which may erode investor confidence.
- Stock Price Reaction: Following the earnings report, VirTra's stock price dropped by $0.43, or 7.93%, closing at $4.99 on November 11, 2025, signaling market concerns regarding the company's financial health.
- Legal Investigation: Pomerantz LLP is investigating whether VirTra and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and potential financial liabilities, impacting the company's future operations and reputation.
Continue Reading